Early disease detection could be as easy as breathing.

Our technology has the potential to detect disease early through a simple breath test.

Results of Breathe BioMedical Inc.’s most recent research support the potential of our technology to detect early-stage breast cancer. Our study identified differences in the breath measurements of women with early-stage breast cancer compared to those without breast cancer with 88.2% accuracy. A sub-group analysis found that breast tissue density had no noticeable effect on the results. This groundbreaking research was conducted by Dr. Farah Naz, using Breathe BioMedical’s technology, and was published as an online abstract at the ASCO 2023 Annual Meeting.
View 2023 ASCO Breast Cancer AbstractView 2022 ASCO Breast Cancer AbstractView Journal of Breath Research PaperView ASCO Lung Cancer AbstractView Breath Biopsy Poster
Early disease detection is key to helping people live longer, healthier lives. Our technology could make the early detection of diseases easier, faster and more accessible than ever before.

Just breathe®


Biomarkers in Breath

When we exhale, there’s much more in our breath than most would ever suspect. Find out more about the way in which we are using breath analytics to change how and when we detect disease.


In the News